Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants-Reference-Cited by-同舟云学术

Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants

Published:2018-11-14 Issue:3 Volume:28 Page:296-304
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Eworuke Efe¹^ORCID,Panucci Genna²,Goulding Margie¹,Neuner Rosemarie³,Toh Sengwee²^ORCID

Affiliation:

1. Division of Epidemiology II, Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MD USA

2. Department of Population Medicine; Harvard Pilgrim Health Care Institute; Boston MA USA

3. Division of Pulmonary, Allergy and Rheumatology Products, Office of New Drugs; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MD USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4695/fullpdf

Reference19 articles.

1. Update on the incidence and prevalence of inflammatory bowel disease in the United States;Loftus;Gastroenterol Hepatol,2016

2. Epidemiological aspects of rheumatoid arthritis: the sex ratio;Kvien;Ann N Y Acad Sci,2006

3. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013